# AstraZeneca Pharmaceuticals, LP - Inspection Records

Source: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/24c4d7fa-217f-4286-8074-011be79e658f

> Inspection records and compliance data for AstraZeneca Pharmaceuticals, LP in Coppell, Texas. Access full analysis and detailed observations.

---

## Details

- Name: AstraZeneca Pharmaceuticals, LP
- FEI Number: 3010199915
- City: Coppell
- State: Texas
- Country Name: United States
- Address Line 1: 508 Wrangler Dr Ste 100
- Zip Code: 75019
- Facility Type: API Manufacturer

## Related Documents

- [FDA Inspection 1312298 - AstraZeneca Pharmaceuticals, LP - 2026-04-03](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f228e59d-a210-4f63-a6cd-18eed36bfcc3) — classification: No Action Indicated (NAI), source: FDA, date: April 3, 2026
- [FDA Inspection 1047488 - AstraZeneca Pharmaceuticals, LP - 2018-03-05](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/14b797dc-6d3c-4ce2-b914-cfae19477953) — classification: No Action Indicated (NAI), source: FDA, date: March 5, 2018
- [483 - AstraZeneca Pharmaceuticals, LP - 2017-01-30](https://www.keypedia.com/records/483/astrazeneca-pharmaceuticals-lp/62ade71b-f812-4696-ad5d-a63ca5c5c2dc) — source: FDA, date: January 30, 2017
- [FDA Inspection 998797 - AstraZeneca Pharmaceuticals, LP - 2017-01-30](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/ee0ecf07-7650-4fab-bc7f-784e9249d085) — classification: Official Action Indicated (OAI), source: FDA, date: January 30, 2017
- [FDA Inspection 963627 - AstraZeneca Pharmaceuticals, LP - 2016-03-29](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/65a34f00-14ed-4660-a63b-a2f0505b795a) — classification: Official Action Indicated (OAI), source: FDA, date: March 29, 2016
- [FDA Inspection 954660 - AstraZeneca Pharmaceuticals, LP - 2015-12-18](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/98ebf08d-1abf-4bab-8398-0d21580ef875) — classification: No Action Indicated (NAI), source: FDA, date: December 18, 2015

## Related Companies

- [Cambrex Charles City, Inc.](https://www.keypedia.com/companies/cambrex-charles-city-inc/b14d342b-e5ae-4df6-ad7a-39cd62dfb9c6)
- [Livzon New North River Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-new-north-river-pharmaceutical-co-ltd/49cdcdc8-9c6c-4486-b6cd-e404c21dd2d2)
- [Shandong Xinhua Pharmaceutical Company Limited](https://www.keypedia.com/companies/shandong-xinhua-pharmaceutical-company-limited/7350901d-493e-45cb-a67f-c73093cf762e)
- [Cambrex Karlskoga AB](https://www.keypedia.com/companies/cambrex-karlskoga-ab/c3f2350f-a38e-4e0c-9bac-e94c0255764c)
- [Neuland Laboratories Limited (Unit I)](https://www.keypedia.com/companies/neuland-laboratories-limited-unit-i/2ab72f34-8d5a-4919-8777-83a4fa3cadd5)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/882d7962-58d4-4de8-9d0b-86bf2cf4773e)
- [Olon S.p.A.](https://www.keypedia.com/companies/olon-spa/7e0ac35e-0f38-43f3-8415-015a3d5c0248)
- [Siegfried PharmaChemikalien Minden Gmbh](https://www.keypedia.com/companies/siegfried-pharmachemikalien-minden-gmbh/711ac70f-e753-40c0-92fd-687cb4eeecc2)
- [Ajinomoto Co., Inc.](https://www.keypedia.com/companies/ajinomoto-co-inc/0cddfef7-b7e4-499f-81aa-0d5e77d331d4)
- [Medichem, S.A.](https://www.keypedia.com/companies/medichem-sa/a0e6f1b5-f2ab-4695-a0e9-007630ef1270)

## Related Officers

- [Biologist at CBER](https://www.keypedia.com/people/massoud-motamed/a8b363de-eb95-4bd3-8c05-9c34bbdbdc8a)
- [Compliance Officer](https://www.keypedia.com/people/jamillah-selby/40c6be13-1980-4b94-9d4d-9e644fad6f8e)